Cargando…

Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective

There is no evidence on benefits or harms of inhaled steroids in COVID-19. It is essential that epidemiological studies of COVID-19 include detailed information on comorbidities and prior medication to help answer this question. https://bit.ly/2XVwIsa

Detalles Bibliográficos
Autores principales:	Halpin, David M.G., Singh, Dave, Hadfield, Ruth M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236828/ https://www.ncbi.nlm.nih.gov/pubmed/32341100 http://dx.doi.org/10.1183/13993003.01009-2020

Ejemplares similares

Inhaled corticosteroids and COVID-19-related mortality: confounding or clarifying?
por: Singh, Dave, et al.
Publicado: (2020)

COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?
por: Maes, Tania, et al.
Publicado: (2020)

One More Time: The Impact of Inhaled Corticosteroid Withdrawal on IMPACT
por: Han, MeiLan K., et al.
Publicado: (2020)

Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review
por: Dyer, Matthew J, et al.
Publicado: (2006)

The polyhedric reality of the interaction between COVID-19, asthma and inhaled corticosteroids
por: Gonzalez-Barcala, Francisco-Javier, et al.
Publicado: (2022)

Before and beyond Inhaled Corticosteroids
por: Vazquez Guillamet, Rodrigo
Publicado: (2020)

Inhaled Corticosteroids and COVID-19
por: Lipworth, Brian, et al.
Publicado: (2020)

Inhaled Corticosteroids and Bronchiectasis: Friend or Foe?
por: Martinez-Garcia, Miguel Angel
Publicado: (2023)

Inhalation Devices
por: Moroni-Zentgraf, Petra, et al.
Publicado: (2018)

The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial
por: Han, MeiLan K., et al.
Publicado: (2020)

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

Inhaled corticosteroids for the treatment of COVID-19
por: Bafadhel, Mona, et al.
Publicado: (2022)

Balancing Benefits and Risks: Do Inhaled Corticosteroids Modify the Lung Microbiome?
por: Singh, Shivani, et al.
Publicado: (2021)

Inhaled corticosteroids: not just for asthma, but for COVID-19?
por: Liew, Felicity, et al.
Publicado: (2022)

How inhaled corticosteroids target inflammation in COPD
por: Lea, Simon, et al.
Publicado: (2023)

Size of Inhaled Corticosteroid and Small Airway Inflammation in Asthma
por: Park, Choon-Sik
Publicado: (2017)

Risk of Pneumonia Associated With the Use of Inhaled Corticosteroids in Asthma
por: Kim, Sang-Heon
Publicado: (2019)

Toward effective prescription of inhaled corticosteroids in chronic airway disease
por: Diamant, Zuzana, et al.
Publicado: (2018)

Inhaled Corticosteroids
por: Barnes, Peter J.
Publicado: (2010)

The efficacy and safety of inhaled corticosteroids: are we ignoring the potential advantages of ciclesonide?
por: van der Molen, Thys, et al.
Publicado: (2014)

Inhaled Corticosteroids for asthma treatment in India: An urgent and radical rethink needed
por: Sovani, Milind P., et al.
Publicado: (2022)

The use of inhaled corticosteroids in early-stage COVID-19
por: Mangin, Dee, et al.
Publicado: (2021)

Inhaled Corticosteroid Withdrawal in Chronic Obstructive Pulmonary Disease: Can IMPACT Help?
por: Suissa, Samy
Publicado: (2020)

Reigniting the TORCH: Chronic Obstructive Pulmonary Disease Mortality and Inhaled Corticosteroids Revisited
por: Calverley, Peter
Publicado: (2021)

Over-the-counter Dispensing: Widening Access to Inhaled Corticosteroid/Formoterol Reliever Therapy
por: Beasley, Richard, et al.
Publicado: (2022)

Inhaled corticosteroids’ effect on COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials
por: Badi, Yasra, et al.
Publicado: (2023)

Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?
por: Nicolau, Dan V, et al.
Publicado: (2020)

Reply to Lipworth et al.: Inhaled Corticosteroids and COVID-19
por: Maes, Tania, et al.
Publicado: (2020)

Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience
por: Adir, Yochai, et al.
Publicado: (2022)

Inhaled corticosteroids for outpatients with COVID-19: a meta-analysis
por: Lee, Todd C., et al.
Publicado: (2022)

COVID-19 and inhaled corticosteroids—another piece in an expanding puzzle
por: Schultze, Anna, et al.
Publicado: (2021)

Inhaled Corticosteroids and Bone Health
por: Chee, Carolyn, et al.
Publicado: (2014)

COVID-19: A rethink of corticosteroid injection?
por: Little, Christopher P., et al.
Publicado: (2020)

Inhaled Corticosteroid Use in Early Childhood: A Risk for High Body Mass Index?
por: Permaul, Perdita, et al.
Publicado: (2021)

Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects
por: Singh, Dave
Publicado: (2020)

Impact of Inhaled Corticosteroids on Growth in Children with Asthma: Systematic Review and Meta-Analysis
por: Loke, Yoon Kong, et al.
Publicado: (2015)

Genetic associations of the response to inhaled corticosteroids in asthma: a systematic review
por: Keskin, Ozlem, et al.
Publicado: (2019)

Relative receptor affinity comparisons among inhaled/intranasal corticosteroids: perspectives on clinical relevance
por: Hochhaus, Günther
Publicado: (2008)

Are intravenous corticosteroid pulses superior to low dose corticosteroids in patients with severe Covid-19?
por: Cordeiro Veiga, Viviane, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_86ac0mmq00ni71l9tg9bgrod5o